Fig. 1
From: MAPK8IP2 is a potential prognostic biomarker and promote tumor progression in prostate cancer
The expression of MAPK8IP2 in prostate cancer and pan-carcinoma. A MAPK8IP2 expression in unpaired tumor tissues and normal tissues of 33 types (TCGA and GTEx). B-E MAPK8IP2 expression levels in prostate cancer tissues and normal prostate tissues of TCGA (C) and GSE70768 (D, E) (paired and unpaired samples). F, G Immunohistochemical staining was used to evaluate the protein expression of MAPK8IP2 in normal tissue (F) and tumor tissue (G). *p < 0.05, **p < 0.01, ***p < 0.001